SCIENTURE HOLDINGS, INC. Increase (Decrease) in Other Accrued Liabilities
SCIENTURE HOLDINGS, INC. (SCNX) reported Increase (Decrease) in Other Accrued Liabilities of -$184.71 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccruedLiabilities · last filed 2017-05-15
- SCIENTURE HOLDINGS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2017-03-31 was -$184.71K, a 274.86% decline year-over-year.
- SCIENTURE HOLDINGS, INC. increase (decrease) in other accrued liabilities for the quarter ending 2016-03-31 was $105.63K.
- SCIENTURE HOLDINGS, INC. increase (decrease) in other accrued liabilities for fiscal 2016 was $233.59K, a 1487.21% increase from fiscal 2015.
- SCIENTURE HOLDINGS, INC. increase (decrease) in other accrued liabilities for fiscal 2015 was $14.72K.
| Period end | Increase (Decrease) in Other Accrued Liabilities 3 month | Increase (Decrease) in Other Accrued Liabilities 12 month |
|---|---|---|
| 2017-03-31 | -$184.71K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $233.59K 10-K · filed 2017-03-30 | |
| 2016-03-31 | $105.63K 10-Q · filed 2017-05-15 | |
| 2015-12-31 | $14.72K 10-K · filed 2017-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |